Enrolling by Invitation
Using CICS-1 and SPM-011 and [18F]FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
NCT06603987
- Conditions
- Adenoma, Breast Diseases, Breast Neoplasms, +40 more
- Locations
-
- ORIX Kouraibashi Bldg. 8F 3-2-7 Kouraibashi Chuo-ku Osaka, Japan